Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system
Although nearly one-half of all patients in a large health care system were AOM-eligible by guidelines and regulatory labeling, only 1% of those who were eligible were prescribed AOMs.
Authors
- Heather J. Baer (ORCID: https://orcid.org/0000-0001-7273-5602)
- John W. Ostrominski (ORCID: https://orcid.org/0000-0002-2866-9414)
- David Zelle (ORCID: https://orcid.org/0000-0001-8193-5067)
- Alexander Blood (ORCID: https://orcid.org/0000-0002-8391-2536)
- Caroline M. Apovian (ORCID: https://orcid.org/0000-0002-8029-1922)
- Kelly Olsson
- Anthony N. Fabricatore
- Kavishwar B. Wagholikar (ORCID: https://orcid.org/0000-0002-6219-861X)
- Benjamin M. Scirica (ORCID: https://orcid.org/0000-0002-7093-7048)
- Jorge Plutzky (ORCID: https://orcid.org/0000-0002-7194-9876)
- Naomi D.L. Fisher (ORCID: https://orcid.org/0000-0003-1649-1441)
- Ozan Ünlü (ORCID: https://orcid.org/0000-0002-0106-5004)
- Joshua C. Toliver (ORCID: https://orcid.org/0000-0002-9159-2587)
- Bríain ó Hartaigh
- Sanjay Kumar (ORCID: https://orcid.org/0000-0002-9737-7327)
- Wojciech Michalak
- Austen M. Smith
- Christopher P. Cannon
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Novo Nordisk (United States) (US)
Publication Details
- Journal
- Obesity
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1002/oby.24186
- Citations
- 6
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.69
Funders
- Novo Nordisk